Results 101 to 110 of about 1,492 (143)
Some of the next articles are maybe not open access.

Hematoporphyrin-Derivative and Photoradiation Therapy of Malignant Tumors

Lasers in Surgery and Medicine, 1983
AbstractKodak projectors with #2418 red Corning filters were used as a light source to treat cutaneous and subcutaneous malignancies in five patients who previously had been given hematoporphyrin derivative (HpD). An argon dye laser system was used to treat malignancies in patients who also were given the HpD.
J S McCaughan
exaly   +3 more sources

Laser photoradiation therapy of cancer following hematoporphyrin sensitization

Lasers in Surgery and Medicine, 1982
AbstractHematoporphyrin derivative‐photoradiation therapy (HPD‐PRT) of human malignancy has been performed on 267 tumor sites in 50 patients. Tumor response has been assayed at 24 hours and one month following treatment with 625–635 nm light from an argon laser‐pumped dye laser.
Michael Berns
exaly   +3 more sources

Evaluation of hematoporphyrin photoradiation therapy to treat choroidal melanomas

Lasers in Surgery and Medicine, 1984
AbstractHematoporphyrin derivative‐photoradiation therapy (HPD‐PRT) was used to treat choroidal melanomas in 23 human subjects. Tumor sizes were divided into three categories: less than 500 mm3 (11 patients), 500‐1,000 mm3 (four patients), and greater than 1,000 mm3 (eight patients). Tumors were exposed to 630 nm laser light at total doses of 300‐3,000
exaly   +3 more sources

Hematoporphyrin derivative and photoradiation therapy in early stage lung cancer

Lasers in Surgery and Medicine, 1984
AbstractPhotoradiation therapy (PDT) with administration of hematoporphyrin derivative (HPD) was performed in ten cases of early stage central‐type lung cancer of which six cases were treated by PRT alone due to inoperability because of poor pulmonary function I five and refusal of surgery on one. Four cases were resected after PRT.
J Ono, C Konaka, Y Hayata
exaly   +3 more sources

Photoradiation of rabbit ocular malignant melanoma sensitized with hematoporphyrin derivative

Current Eye Research, 1984
Photoradiation therapy (PRT) against the Greene-Harvey amelanotic malignant melanoma on the rabbit iris was effectively used to cause tumor regression. A dose of 2.5 mg/kg of hematoporphyrin derivative (HPD) given intravenously, followed by photoradiation at a wavelength of 632 nm and a power density as low as 71 mW/cm2 for 24 minutes (102 J/cm2) was ...
T J Dougherty
exaly   +3 more sources

Hematoporphyrin Derivative and Laser Photoradiation in the Treatment of Lung Cancer

Chest, 1982
Photoradiation therapy (PRT) was performed in 13 lung cancer cases and in one case of severely atypical squamous metaplasia following administration of hematoporphyrin derivative (HpD). The HpD is activated by visible red light (630 nm, 90 to 400 mW) from an argon dye laser.
J Ono, Jutaro Ono, C Konaka
exaly   +3 more sources

Intra-Abdominal Applications of Hematoporphyrin Photoradiation Therapy

open access: yes, 1983
At Roswell Park Memorial Institute (RPMI), long experience in the management of tumors with hematoporphyrin derivative (HPD) photoradiation therapy (PRT) has documented the destruction of a wide range of neoplasms with remarkable regularity (1,2). The surrounding inflammatory response and eschar that formed at the site of the tumor nodule indicated ...
H O, Douglass   +6 more
openaire   +3 more sources

DNA damage and repair in CHO cells following hematoporphyrin photoradiation

Cancer Letters, 1980
The induction and repair of alkali labile lesions and single strand breaks in DNA of CHO cells following HpD photoradiation of X-irradiation has been examined. For treatments producing equal survival levels, the amount of DNA damage was less for HpD-photoradiated cells compared to X-irradiated cells.
Charles J Gomer
exaly   +3 more sources

Photoradiation Therapy with Hematoporphyrin Derivative in Early and Stage 1 Lung Cancer

Chest, 1984
Photoradiation therapy with hematoporphyrin derivative was used in 13 cases of early-stage and eight cases of stage 1 central-type lung cancer. The lesions were photoradiated superficially or interstitially by an argon dye laser with a power of 80 to 600 mW for 10 to 40 minutes at 48 hours or more after intravenous injection of 2.5 to 5.0 mg of ...
J Ono, Jutaro Ono, C Konaka
exaly   +3 more sources

Hematoporphyrin derivative photoradiation therapy of the rat 9L gliosarcoma brain tumor model

Lasers in Surgery and Medicine, 1984
AbstractThe distribution of hematoporphyrin derivative (HPD) in the rat 9L gliosarcoma intracerebral brain tumor model at 4, 24, 48, and 72 hours after intravenous administration was evaluated using a digital video fluorescence microscopy technique. Maximum tissue fluorescence in the normal brain was observed at 4 hours, whereas maximum fluorescence in
Michael Berns, M S Edwards
exaly   +3 more sources

Home - About - Disclaimer - Privacy